Changes in prevalence and sociodemographic correlates of tobacco and nicotine use in Finland during the COVID-19 pandemic
European Journal of Public Health · 2023
DOI: 10.1093/eurpub/ckad104 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Public Health, 2023. Verfasst von Sebastián Peña und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland. Hauptthemen laut MEDLINE: COVID-19, Tobacco Use, Smoking. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NordForsk.
Abstract (Originalsprache)
Background
The impact of the coronavirus disease 2019 (COVID-19) pandemic on tobacco and nicotine use remains debated. We examined whether the prevalence of tobacco and nicotine use and nicotine-replacement therapy (NRT) changed during the COVID-19 pandemic and whether changes differed by sociodemographic groups.
Methods
Repeated cross-sectional study of three national surveys in Finland (2018, 2019 and 2020; n = 58 526 adults aged 20 and over). Outcomes were daily and occasional smoking, smokeless tobacco (snus) use, e-cigarettes use, total tobacco or nicotine use and NRT use. We examined changes for each outcome by sex, age, educational tertiles, marital status, mother tongue and social participation.
Results
Daily smoking decreased among males by 1.15 percentage points (pp) [95% confidence interval (CI) −2.10 to −0.20] between 2018 and 2020 and 0.86 pp among females (95% CI −1.58 to −0.15). Daily snus use remained stable in both sexes. Daily e-cigarette use was below 1% and remained stable. We found weak evidence of a reduction in total tobacco or nicotine use between 2018 and 2020 (males −1.18 pp, 95% CI −2.68 to 0.32 and females −0.8 pp, 95% CI −1.81 to 0.22). NRT use remained stable. Snus and NRT use decreased among 60- to 74-year-olds but remained stable in other age groups. We did not find evidence of interactions by subgroup for other outcomes.
Conclusions
Daily smoking decreased in Finland between 2018 and 2020, but other forms of tobacco use did not experience a reduction. The COVID-19 pandemic does not seem to have altered the sustained reduction of smoking in Finland, although substantial sociodemographic differences persist.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
ORCID-Profile: Sebastián Peña, Otto Ruokolainen, Sakari Karvonen
Förderung
- NordForsk
Zitieren
APA
Peña, S., Ilmarinen, K., Kestilä, L., Ruokolainen, O., Ollila, H., Parikka, S., & Karvonen, S. (2023). Changes in prevalence and sociodemographic correlates of tobacco and nicotine use in Finland during the COVID-19 pandemic. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckad104
Vancouver
Peña S, Ilmarinen K, Kestilä L, Ruokolainen O, Ollila H, Parikka S, et al. Changes in prevalence and sociodemographic correlates of tobacco and nicotine use in Finland during the COVID-19 pandemic. European Journal of Public Health. 2023. doi:10.1093/eurpub/ckad104
BibTeX
@article{Pea2023,
author = {Peña, Sebastián and Ilmarinen, Katja and Kestilä, Laura and Ruokolainen, Otto and Ollila, Hanna and Parikka, Suvi and Karvonen, Sakari},
title = {Changes in prevalence and sociodemographic correlates of tobacco and nicotine use in Finland during the COVID-19 pandemic},
journal = {European Journal of Public Health},
year = {2023},
doi = {10.1093/eurpub/ckad104}
}
EUVIMED